Gene · 970
Papers4,349
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,801 to 1,820 of 4,349
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Discovery of targeted expression data for novel antibody-based and chimeric antigen receptor-based therapeutics in soft tissue sarcomas using RNA-sequencing: clinical implications. | Curr Probl Cancer | 2021 | 34656365 | PubTator, text mining | PubMed |
| mRNA - A game changer in regenerative medicine, cell-based therapy and reprogramming strategies. | Adv Drug Deliv Rev | 2021 | 34653534 | PubTator, text mining | PubMed |
| Identification and Validation of Hypoxia-Related lncRNA Signature as a Prognostic Model for Hepatocellular Carcinoma. | Front Genet | 2021 | 34650600 | PubTator, text mining | PubMed |
| Therapeutically expanded human regulatory T-cells are super-suppressive due to HIF1A induced expression of CD73. | Commun Biol | 2021 | 34650224 | PubTator, text mining | PubMed |
| Pan-cancer analysis of the prognostic and immunological role of PSMB8. | Sci Rep | 2021 | 34650125 | PubTator, text mining | PubMed |
| Full-Length Transcriptome: A Reliable Alternative for Single-Cell RNA-Seq Analysis in the Spleen of Teleost Without Reference Genome. | Front Immunol | 2021 | 34646272 | PubTator, text mining | PubMed |
| A Chimeric IL-15/IL-15Rα Molecule Expressed on NFκB-Activated Dendritic Cells Supports Their Capability to Activate Natural Killer Cells. | Int J Mol Sci | 2021 | 34638566 | PubTator, text mining | PubMed |
| Immune Therapies for Myelodysplastic Syndromes and Acute Myeloid Leukemia. | Cancers (Basel) | 2021 | 34638510 | PubTator, text mining | PubMed |
| Evaluation of Comprehensive Gene Expression and NK Cell-Mediated Killing in Glioblastoma Cell Line-Derived Spheroids. | Cancers (Basel) | 2021 | 34638384 | PubTator, text mining | PubMed |
| High Prevalence of 5T4/Trophoblast Glycoprotein in Soft Tissue Sarcomas. | Cancers (Basel) | 2021 | 34638324 | PubTator, text mining | PubMed |
| Keeping Myeloma in Check: The Past, Present and Future of Immunotherapy in Multiple Myeloma. | Cancers (Basel) | 2021 | 34638271 | PubTator, text mining | PubMed |
| Epstein-Barr Virus in Inborn Immunodeficiency-More Than Infection. | Cancers (Basel) | 2021 | 34638238 | PubTator, text mining | PubMed |
| Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives. | Mol Cancer | 2021 | 34635121 | PubTator, text mining | PubMed |
| Recent Advances in Experimental Dendritic Cell Vaccines for Cancer. | Front Oncol | 2021 | 34631558 | PubTator, text mining | PubMed |
| Molecular Analysis of Prognosis and Immune Pathways of Pancreatic Cancer Based on TNF Family Members. | J Oncol | 2021 | 34630563 | PubTator, text mining | PubMed |
| Targeting the CD27-CD70 Pathway to Improve Outcomes in Both Checkpoint Immunotherapy and Allogeneic Hematopoietic Cell Transplantation. | Front Immunol | 2021 | 34630390 | PubTator, text mining | PubMed |
| Pattern Recognition Proteins: First Line of Defense Against Coronaviruses. | Front Immunol | 2021 | 34630377 | PubTator, text mining | PubMed |
| An overview of multiplexed analyses of CAR T-cell therapies: insights and potential. | Expert Rev Proteomics | 2021 | 34628995 | PubTator, text mining | PubMed |
| Development of a Toll-Like Receptor-Based Gene Signature That Can Predict Prognosis, Tumor Microenvironment, and Chemotherapy Response for Hepatocellular Carcinoma. | Front Mol Biosci | 2021 | 34621787 | PubTator, text mining | PubMed |
An Integrative Pan-Cancer Analysis of the Prognostic and Immunological Role of Casein Kinase 2 Alpha Protein 1 (CSNK2A1) in Human Cancers: A Study Based on Bioinformatics and Immunohistochemical Analysis. | Int J Gen Med | 2021 | 34621130 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/970/papers?page=91